Several reports have highlighted the increased expression of antioxidant enzymes, such as SOD1 and SOD2, and catalase in actively demyelinating MS lesions; hence, increased expression of antioxidant enzymes in inflammatory MS lesions is associated with neuroinflammation [117, 128]. The gene discussed is SOD1; the disease is myeloid sarcoma.